Michael Mack, MD, and Robert Stoler, MD
Healio spoke with two clinicians from Baylor Scott and White Health about transcatheter aortic valve replacement.
In this video series, Michael Mack, MD, cardiac and thoracic surgeon, and Robert C. Stoler, MD, interventional cardiologist, discussed:
- recent updates to TAVR guidelines, highlighting “the biggest change” is from a risk-based assessment to an age-based assessment;
- the safety, efficacy and durability of TAVR;
- lifetime management of younger and healthier patients undergoing TAVR;
- what collaborative care between primary cardiologists, interventional cardiologists and cardiac surgeons looks like;
- the importance of referring patients for TAVR; and
- gaps in knowledge.
Disclosures:
Mack reports serving as a national co-primary investigator and study chair with Abbott, Edward Life Sciences and Medtronic. Stoler reports serving on the advisory boards of Biotronik, Boston Scientific, Edward Life Sciences and Medtronic; and serving as a case proctor for Edward Life Sciences and Medtronic.
Click Here to Manage Email Alerts